pharmacie et médicaments – Prise en charge des anticorps monoclonaux pour les patients sans alternative ?

This written question asks about the coverage of monoclonal antibodies for patients who have no other treatment options available. It highlights a potential gap in healthcare access for certain medical conditions. The question seeks clarification on how these advanced therapies are funded and made accessible, potentially affecting patients with rare diseases or specific cancers and their healthcare providers.